Literature DB >> 20007348

Loss of clusterin expression worsens renal ischemia-reperfusion injury.

Wenjun Zhou1, Qiunong Guan, Chris C H Kwan, Huifang Chen, Martin E Gleave, Christopher Y C Nguan, Caigan Du.   

Abstract

Prevention of ischemia-reperfusion injury (IRI) is a challenge in clinical care of the patients with kidney transplants or acute kidney injury, and understanding of the intrinsic mechanisms of resistance to injury in the kidney will lead to a novel therapy. Clusterin, a secreted glycoprotein, is an antiapoptotic protein in cancer cells. Our study is to investigate the role of clusterin in renal IRI. Renal IRI in mice was induced by clamping renal vein and artery for 45 or 50 min at 32 degrees C. Apoptosis of renal tubular epithelial cells (TECs) was determined by FACS analysis. Clusterin expression was examined by Western blot or immunohistochemistry. Here, we showed that clusterin protein was induced in TECs following IRI, and more tubules expressed clusterin in the kidneys following ischemia at higher temperatures. In human proximal TEC HKC-8 cultures, clusterin was upregulated by removal of serum and growth factors in medium and was downregulated by TNF-alpha-IFN-gamma mixture. The levels of clusterin were positively correlated with cell survival in these conditions. Knockdown or knockout of clusterin expression enhanced the sensitivity of TECs to apoptosis. In experimental models of renal IRI, deficiency in clusterin expression worsened the injury, as indicated by a significant increase in renal tissue damage with higher levels of serum creatinine and blood urea nitrogen and by a poorer recovery from the injury in clusterin-deficient mice compared with wild-type mice. Our data indicate that the reduction of inducible expression of clusterin results in an increase in TEC apoptosis in the cultures and renders mice susceptibility to IRI, implying a protective role of clusterin in kidney injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20007348     DOI: 10.1152/ajprenal.00399.2009

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  15 in total

1.  Calcium oxalate calculi-induced clusterin expression in kidney.

Authors:  Jin-Yi Li; Junjiang Liu; Junyi Jiang; Chris Pumill; Cordelia Elaiho; Yunxia Zhang; Shoubin Li; Tie Zhou
Journal:  Urolithiasis       Date:  2015-05-21       Impact factor: 3.436

2.  Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetes.

Authors:  Daniela Schlatzer; David M Maahs; Mark R Chance; Jean-Eudes Dazard; Xiaolin Li; Fred Hazlett; Marian Rewers; Janet K Snell-Bergeon
Journal:  Diabetes Care       Date:  2012-01-11       Impact factor: 19.112

3.  FK506 reduces calpain-regulated calcineurin activity in both the cytoplasm and the nucleus.

Authors:  Sun Hee Lee; Jungil Choi; Hwajin Kim; Dong Hoon Lee; Gu Seob Roh; Hyun Joon Kim; Sang Soo Kang; Wan Sung Choi; Gyeong Jae Cho
Journal:  Anat Cell Biol       Date:  2014-06-20

4.  Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injury.

Authors:  Jia Guo; Qiunong Guan; Xiuheng Liu; Hao Wang; Martin E Gleave; Christopher Y C Nguan; Caigan Du
Journal:  BMC Nephrol       Date:  2016-09-20       Impact factor: 2.388

5.  Verteporfin blocks Clusterin which is required for survival of gastric cancer stem cell by modulating HSP90 function.

Authors:  Jixian Xiong; Shaoxiang Wang; Tie Chen; Xingsheng Shu; Xianming Mo; Gang Chang; Jia-Jie Chen; Chenyang Li; Hui Luo; Jiing-Dwan Lee
Journal:  Int J Biol Sci       Date:  2019-01-01       Impact factor: 6.580

6.  Clusterin as a potential marker of brain ischemia-reperfusion injury in patients undergoing carotid endarterectomy.

Authors:  Joanna Iłżecka; Marek Iłżecki; Aneta Grabarska; Shawn Dave; Marcin Feldo; Tomasz Zubilewicz
Journal:  Ups J Med Sci       Date:  2019-08-28       Impact factor: 2.384

7.  Brain clusterin protein isoforms and mitochondrial localization.

Authors:  Sarah K Herring; Hee-Jung Moon; Punam Rawal; Anindit Chhibber; Liqin Zhao
Journal:  Elife       Date:  2019-11-18       Impact factor: 8.140

8.  The use of urinary and kidney SILAM proteomics to monitor kidney response to high dose morpholino oligonucleotides in the mdx mouse.

Authors:  Aiping Zhang; Kitipong Uaesoontrachoon; Conner Shaughnessy; Jharna R Das; Sree Rayavarapu; Kristy J Brown; Patricio E Ray; Kanneboyina Nagaraju; John N van den Anker; Eric P Hoffman; Yetrib Hathout
Journal:  Toxicol Rep       Date:  2015

9.  Comparative transcriptional profiling of renal cortex in rats with inherited stress-induced arterial hypertension and normotensive Wistar Albino Glaxo rats.

Authors:  Larisa A Fedoseeva; Marina A Ryazanova; Nikita I Ershov; Arcady L Markel; Olga E Redina
Journal:  BMC Genet       Date:  2016-01-27       Impact factor: 2.797

10.  Clusterin exerts a cytoprotective and antioxidant effect in human osteoarthritic cartilage.

Authors:  Chiara Tarquini; Sabina Pucci; Maria Giovanna Scioli; Elena Doldo; Sara Agostinelli; Federico D'Amico; Alessandra Bielli; Amedeo Ferlosio; Emanuele Caredda; Umberto Tarantino; Augusto Orlandi
Journal:  Aging (Albany NY)       Date:  2020-06-09       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.